However, preliminary studies in stressed rats with depression and pseudodementia like symptoms showed that the administration of triptans, in particular, zolmitriptan, might act as a 5-HT-1B agonist and therefore decrease depression symptoms [46]. This evidence concerns the gene HTR1B and major depressive disorder.